Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
M. I. Husain, D. M. Blumberger, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
P. R. Shiroma, P. Thuras, et al.
Protocol for the Work Engagement and Well-being Study (SWELL): a randomised controlled feasibility trial evaluating the effects of mindfulness versus light physical exercise at work
M. Vainre, J. Galante, et al.
The effects of omega 3 fatty acids on the serum concentrations of pro inflammatory cytokines and depression status in patients with bipolar disorder: A randomized double-blind controlled clinical trial
H. Eslahi, M. Shakiba, et al.
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
F. Holze, L. Ley, et al.
